[PMID: 7802710] PubMed record related to this compound for laboratory literature review
Several experts advise to lower the dose of sulfonylurea and short-acting and low-acting insulin analogues prior to or during titration of GLP-1RA therapy, to reduce the risk of (severe) hypoglycemia ( Gastrointestinal (GI) Adverse Effects In the phase 3 trials, both oral and subcutaneous semaglutide were associated with gastrointestinal disturbances, such as nausea, vomiting and diarrhea, well-known effects from this drug class
Spiekerkoetter, U., Bastin, J., Gillingham, M., Morris, A., Wijburg, F., and Wilcken, B
Eng found that Gila monsters secreted a salivary venom peptide, now known as exendin-4
,
Semaglutide alternatives Semaglutide is only one type of GLP-1 agonist medication